Ï㽶ÊÓƵ

ɱ¹Ã©²Ô±ð³¾±ð²Ô³Ù

Ethical, Legal and Social Considerations on Precision Medicine in the Republic of Korea

Jeudi, 11 janvier, 2018 12:30à14:00
Pavillon Strathcona (anatomie et médecine dentaire) Salle 3M-48, 3640, rue University, Montréal, QC, H3A 0C7, CA
Prix: 
Gratuit

Le Groupe de recherche en santé et droit de McGill (GRSD), en collaboration avec le Centre de génomique et politiques, annonce la tenue d’un séminaire intitulé Ethical, Legal and Social Considerations on Precision Medicine in the Republic of Korea.

Le séminaire sera en anglais et sera présenté par Dr So Yoon Kim, professeure de droit médical et de bioéthique au Collège de médecine de l’Université Yonsei (Séoul, Corée du Sud). L'évènement se déroulera le jeudi 11 janvier 2018 de 12h30 à 14h00 au local 3M-48 du Pavillon Strathcona de l'Université McGill (3640 rue University, Montréal). 

Résumé (en anglais)

Korean biobanks are now changing to integrate the new paradigm of precision medicine into their fundamental role of promoting health technology. Since the enactment of Bioethics and Safety Act in 2004, the Republic of Korea has developed a regulatory framework that reflects ethical principles. However, the regulation of biobanks has recently proven to be limited in responding to newer ethical and legal issues that have arisen. First, as there is an emerging trend for human biospecimens to be stored, managed and distributed as digitalized data, the current role of the Distributive Review Committee may become less important compared to the Data Access Committee. Second, even if public health data is anonymised, the risk of identifiability is growing. This makes a third point relevant, informed consent is crucial to respect the autonomy of patients and research subjects, but current consent rules need to change to reflect the interactive and dynamic communication process, increasingly being realized in Information and Communication Technology (ICT). Fourth, even though data sharing for research is expected to be altruistic and the sale of human biospecimens and genome data remains prohibited, current data sharing practices have become more complicated, and are closer to commercial use and commercialisation. Given these challenges, continuing and deeper deliberation must be carried out in order to develop a more comprehensive and responsive governance framework.

L’évènement est gratuit, mais l’inscription est nécessaire puisque les places sont limitées. Merci de confirmer votre présence en envoyant un courriel au rghl.law [at] mcgill.ca. Un léger repas sera servi.

Back to top